Actively Recruiting
Prevalence of FGIDs and Probiotics Study
Led by Chulalongkorn University · Updated on 2025-07-02
512
Participants Needed
1
Research Sites
98 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a study to evaluate the prevalence of FGIDs in infants using the Thai version of Rome IV diagnostic questionnaire for functional gastrointestinal disorders in infants and evaluate the efficacy of Limosilactobacillus reuteri DSM 17938 to prevent FGIDs in infants.
CONDITIONS
Official Title
Prevalence of FGIDs and Probiotics Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Healthy and full-term infants born at 37 to 41 weeks gestation
- Appropriate weight for age
- APGAR score more than 8 at 10 minutes after birth
- Normal physical examination
- Mothers have not used probiotics before
You will not qualify if you...
- Not willing to participate in the study
- Unable to attend follow-up visits until 1 year of age
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Maha Chakri Sirindhorn Clinical Research Center (Chula CRC)
Bangkok, Bangkok, Thailand, 10330
Actively Recruiting
Research Team
P
Palittiya Sintusek, PhD
CONTACT
S
Sittichoke Prachuapthunyachart, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here